MAINZ, GERMANY, and SINGAPORE, November 14, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had ...
CAMBRIDGE, MA -- A three-year research program led by faculty at MIT aims to design the world’s first fully integrated, continuous mRNA manufacturing platform, in an $82 million effort funded by the U ...
Through this partnership, Sensible and Ginkgo aim to develop an in vivo alternative to conventional in vitro mRNA production technology OXFORD, United Kingdom, April 3, 2023 /PRNewswire/ -- Sensible ...
- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times - STONY BROOK, NY and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback